Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

Resources

Depression Akathisia from Antidepressants
April 23, 2024in Depression 0 Comments 0 Likes

Akathisia from Antidepressants

Finding the right treatment plan to combat major depressive disorder (MDD) is a complicated and delicate endeavor.  While some antidepressants may work to help alleviate the daily burdens of Depression,

by Dr. Bryan Bruno, Medical Director
Depression Esketamine (Spravato) Treatment as Part of a Depression Relapse Prevention Plan
April 21, 2024in Depression 0 Comments 0 Likes

Esketamine (Spravato) Treatment as Part of a Depression Relapse Prevention Plan

Although millions of people are empowered to coexist with their Depression through comprehensive and personalized treatment plans, the long-term management of this condition can often be complicated by the potential

by Dr. Bryan Bruno, Medical Director
Depression Paradoxical Effect of Antidepressants: Can These Medications Sometimes Do More Harm Than Good?
April 18, 2024in Depression 0 Comments 0 Likes

Paradoxical Effect of Antidepressants: Can These Medications Sometimes Do More Harm Than Good?

Over the years, countless patients have turned to antidepressants as a definitive answer to their complex psychological challenges such as major depressive disorder (MDD), clinical anxiety, and panic disorder. As

by Dr. Bryan Bruno, Medical Director
Depression Antidepressant Induced Mania
April 11, 2024in Depression 0 Comments 0 Likes

Antidepressant Induced Mania

For decades, antidepressants such as SSRIs have long been regarded as first-line treatment for major depressive disorder (MDD) and other mood disorders; their importance across many different demographics continues to

by Dr. Bryan Bruno, Medical Director
Depression A Study of Single-Dose Psilocybin Treatment for Major Depressive Disorder
March 24, 2024in Depression 0 Comments 0 Likes

A Study of Single-Dose Psilocybin Treatment for Major Depressive Disorder

Psilocybin Treatment for Major Depressive Disorder (MDD) is a topic of interest for some of the many people struggling with debilitating symptoms of Depression. While not currently approved for the

by Dr. Bryan Bruno, Medical Director
Resources How to Avoid Employee Burnout
June 7, 2022in Resources 0 Comments 0 Likes

How to Avoid Employee Burnout

If you’re wondering how to avoid employee burnout, it’s important that you first understand what causes it. Burnout is disastrous for employee productivity, and has the potential to leak into

by Dr. Bryan Bruno, Medical Director
Resources Mental Health Resources for TMS Patients
October 20, 2018in Resources 0 Comments 0 Likes

Mental Health Resources for TMS Patients

Living life with mental health conditions is undeniably difficult, especially when you don’t know where to go for help and support. At Mid City TMS, our support for our patients’

by Dr. Bryan Bruno, Medical Director
Prev

Posts navigation

  • 1
  • 2
Next

Recent Posts

  • Can Exercise Treat Depression?
  • Antidepressant Weight Gain: A Recent Study
  • Can Spravato (Esketamine) Transform Treatment-Resistant Depression? Insights from a Recent Study
  • Comparing TMS With Other Antidepressant Treatments
  • A New Era in Mental Health: Ketamine-Based Therapies for Treatment-Resistant Depression

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}